Challenges and Opportunities in Combining Radiotherapy and Immunotherapy for Localized Pancreatic Cancer

Expanding preclinical and clinical literature from PDAC and other oncological indications identifies novel approaches through which radiation therapy–immunotherapy combinations could improve local and systemic disease control in patients with PDAC.